약학회지
YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 1.

Table. 1.

Scale of global pharmaceutical companies located in Korea between 2016 and 2020.

Year
2016 2017 2018 2019 2020
n=25 n=25 Rate (%)* n=27 Rate (%)* n=31 Rate (%)* n=31 Rate (%)*
Costs (unit: million won)
Overall companies 361,756 400,008 10.6 470,698 17.7 483,655 2.8 596,281 23.3
25 companies** 360,035 395,555 9.9 457,638 15.7 475,973 4.0 590,185 24.0
Personnel
Overall companies 1,385 1,540 11.2 1,660 7.8 1,699 2.3 1,846 8.7
25 companies** 1,363 1,513 11.0 1,597 5.6 1,603 0.4 1,755 9.5
Number of clinical trials†
Overall companies 1,189 1,273 7.1 1,325 4.1 1,347 1.7 1,319 -2.1
25 companies** 1,155 1,230 6.5 1,275 3.7 1,272 -0.2 1,280 0.6
Number of clinical trials subject††
Overall companies 41,496 35,450 -14.6 50,578 42.7 46,332 -8.4 30,108 -35.0
25 companies** 41,276 35,155 -14.8 49,687 41.3 45,129 -9.2 28,751 -36.3

*Rate=(value of the year-value of previous year)/value of previous year*100

**Companies which participate for five years.

†Including Phase I, II, III, IV (Interventional study, Non-interventional study), and other trials(Pharmaco-economic/Outcome research, Investigator Initiated Trial).

††Including Phase I, II, III, IV (Interventional study), and other study(Investigator Initiated Trial).

Yakhak Hoeji 2021;65:494-501 https://doi.org/10.17480/psk.2021.65.6.494
© 2021 Yakhak Hoeji